South Korea Active Pharmaceutical Ingredients Market 规模与份额分析 - 成长趋势与预测 (2024 - 2031)
South Korea Active Pharmaceutical Ingredients Market is Segmented By Product Type (Low Potent APIs, High Potent APIs), By Molecular Type (Small Molecules, Large Molecules), By Formulation (Oral, Topical, Injectables, Drops), By Application (Diabetes, Oncology, Cardiovascular, CNS, Analgesics, Ophthalmic, Respiratory, Dermatology, Others). The report offers the value (in USD Billion) for the above-mentioned segments
Competitive overview of South Korea Active Pharmaceutical Ingredients Market
韩国活跃药材市场的主要运营商包括泰娃药业有限公司,京波药业,SAMOH. 菩萨. 联合有限公司, SHINPONG.CO、LTD、Kukjeon制药有限公司、汉密制药公司。 Co.,Ltd., abcr GmbH, Porpharma, Lupin, 和 JEIL PHARMACEUTICAL CO., LTD. 互联网档案馆的存檔,存档日期2014-12-20.
South Korea Active Pharmaceutical Ingredients Market Leaders
- 泰瓦制药公司 实业有限公司.
- 庆波药
- 萨摩亚 药业股份有限公司.
- (原始内容存档于2019-09-26). SHINPOONG.CO, LTD
- 库克坚制药有限公司.
*Disclaimer: Major players are listed in no particular order.
South Korea Active Pharmaceutical Ingredients Market - Competitive Rivalry, 2023
South Korea Active Pharmaceutical Ingredients Market
Market Consolidated
(Dominated by major players)
(Dominated by major players)
Market Fragmented
(Highly competitive with lots of players.)
(Highly competitive with lots of players.)
*Source: Coherent Market Insights